{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:03:40Z","timestamp":1773691420846,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"medical class of 1961 research bursary"},{"name":"harold and rhea pugash research bursary"},{"DOI":"10.13039\/501100000024","name":"canadian institutes of health research","doi-asserted-by":"publisher","award":["144213"],"award-info":[{"award-number":["144213"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10048-022-00684-7","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T04:43:13Z","timestamp":1643776993000},"page":"115-127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical, neuroradiological, and molecular characterization of patients with atypical Zellweger spectrum disorder caused by PEX16 mutations: a case series"],"prefix":"10.1007","volume":"23","author":[{"given":"Anthony","family":"Cheung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Argyriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Yergeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmin","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9milie","family":"Riou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"L\u00e9vesque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mebratu","family":"Daba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irakli","family":"Rtskhiladze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tinatin","family":"Tkemaladze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Adang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"La Piana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevi\u00e8ve","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1621-5164","authenticated-orcid":false,"given":"Nancy","family":"Braverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"key":"684_CR1","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.bbamcr.2015.11.015","volume":"1863","author":"HR Waterham","year":"2016","unstructured":"Waterham HR, Ferdinandusse S, Wanders RJA (2016) Human disorders of peroxisome metabolism and biogenesis. Biochim Biophys Acta BBA - Mol Cell Res 1863:922\u2013933. https:\/\/doi.org\/10.1016\/j.bbamcr.2015.11.015","journal-title":"Biochim Biophys Acta BBA - Mol Cell Res"},{"key":"684_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00418-018-1722-5","volume":"150","author":"M Islinger","year":"2018","unstructured":"Islinger M, Voelkl A, Fahimi HD, Schrader M (2018) The peroxisome: an update on mysteries 2.0. Histochem Cell Biol 150:443\u2013471. https:\/\/doi.org\/10.1007\/s00418-018-1722-5","journal-title":"Histochem Cell Biol"},{"key":"684_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-030-60204-8_1","volume":"1299","author":"K Okumoto","year":"2020","unstructured":"Okumoto K, Tamura S, Honsho M, Fujiki Y (2020) Peroxisome: metabolic functions and biogenesis. Adv Exp Med Biol 1299:3\u201317. https:\/\/doi.org\/10.1007\/978-3-030-60204-8_1","journal-title":"Adv Exp Med Biol"},{"key":"684_CR4","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.bbamcr.2016.01.020","volume":"1863","author":"R Erdmann","year":"2016","unstructured":"Erdmann R (2016) Assembly, maintenance and dynamics of peroxisomes. Biochim Biophys Acta 1863:787\u2013789. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.01.020","journal-title":"Biochim Biophys Acta"},{"key":"684_CR5","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.bbamcr.2015.09.026","volume":"1863","author":"R Hua","year":"2016","unstructured":"Hua R, Kim PK (2016) Multiple paths to peroxisomes: mechanism of peroxisome maintenance in mammals. Biochim Biophys Acta BBA - Mol Cell Res 1863:881\u2013891. https:\/\/doi.org\/10.1016\/j.bbamcr.2015.09.026","journal-title":"Biochim Biophys Acta BBA - Mol Cell Res"},{"key":"684_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature21375","volume":"542","author":"A Sugiura","year":"2017","unstructured":"Sugiura A, Mattie S, Prudent J, McBride HM (2017) Newly born peroxisomes are a hybrid of mitochondrial and ER-derived pre-peroxisomes. Nature 542:251\u2013254. https:\/\/doi.org\/10.1038\/nature21375","journal-title":"Nature"},{"key":"684_CR7","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1083\/jcb.200806062","volume":"183","author":"T Matsuzaki","year":"2008","unstructured":"Matsuzaki T, Fujiki Y (2008) The peroxisomal membrane protein import receptor Pex3p is directly transported to peroxisomes by a novel Pex19p- and Pex16p-dependent pathway. J Cell Biol 183:1275\u20131286. https:\/\/doi.org\/10.1083\/jcb.200806062","journal-title":"J Cell Biol"},{"key":"684_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1083\/jcb.200304111","volume":"164","author":"JM Jones","year":"2004","unstructured":"Jones JM, Morrell JC, Gould SJ (2004) PEX19 is a predominantly cytosolic chaperone and import receptor for class 1 peroxisomal membrane proteins. J Cell Biol 164:57\u201367. https:\/\/doi.org\/10.1083\/jcb.200304111","journal-title":"J Cell Biol"},{"key":"684_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3233\/TRD-160003","volume":"1","author":"C Argyriou","year":"2016","unstructured":"Argyriou C, D\u2019Agostino MD, Braverman N (2016) Peroxisome biogenesis disorders. Transl Sci Rare Dis 1:111\u2013144. https:\/\/doi.org\/10.3233\/TRD-160003","journal-title":"Transl Sci Rare Dis"},{"key":"684_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ymgme.2015.12.009","volume":"117","author":"NE Braverman","year":"2016","unstructured":"Braverman NE, Raymond GV, Rizzo WB et al (2016) Peroxisome biogenesis disorders in the Zellweger spectrum: an overview of current diagnosis, clinical manifestations, and treatment guidelines. Mol Genet Metab 117:313\u2013321. https:\/\/doi.org\/10.1016\/j.ymgme.2015.12.009","journal-title":"Mol Genet Metab"},{"key":"684_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13023-015-0368-9","volume":"10","author":"FCC Klouwer","year":"2015","unstructured":"Klouwer FCC, Berendse K, Ferdinandusse S et al (2015) Zellweger spectrum disorders: clinical overview and management approach. Orphanet J Rare Dis 10:151. https:\/\/doi.org\/10.1186\/s13023-015-0368-9","journal-title":"Orphanet J Rare Dis"},{"key":"684_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/8904_2011_102","volume":"6","author":"A Mignarri","year":"2012","unstructured":"Mignarri A, Vinciguerra C, Giorgio A et al (2012) Zellweger spectrum disorder with mild phenotype caused by PEX2 gene mutations. JIMD Rep 6:43\u201346. https:\/\/doi.org\/10.1007\/8904_2011_102","journal-title":"JIMD Rep"},{"key":"684_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/ana.22035","volume":"68","author":"L R\u00e9gal","year":"2010","unstructured":"R\u00e9gal L, Ebberink MS, Goemans N et al (2010) Mutations in PEX10 are a cause of autosomal recessive ataxia. Ann Neurol 68:259\u2013263. https:\/\/doi.org\/10.1002\/ana.22035","journal-title":"Ann Neurol"},{"key":"684_CR14","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ymgme.2004.08.008","volume":"83","author":"S Steinberg","year":"2004","unstructured":"Steinberg S, Chen L, Wei L et al (2004) The PEX Gene Screen: molecular diagnosis of peroxisome biogenesis disorders in the Zellweger syndrome spectrum. Mol Genet Metab 83:252\u2013263. https:\/\/doi.org\/10.1016\/j.ymgme.2004.08.008","journal-title":"Mol Genet Metab"},{"key":"684_CR15","doi-asserted-by":"publisher","first-page":"E467","DOI":"10.1002\/humu.20932","volume":"30","author":"WY Yik","year":"2009","unstructured":"Yik WY, Steinberg SJ, Moser AB et al (2009) Identification of novel mutations and sequence variation in the Zellweger syndrome spectrum of peroxisome biogenesis disorders. Hum Mutat 30:E467-480. https:\/\/doi.org\/10.1002\/humu.20932","journal-title":"Hum Mutat"},{"key":"684_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/humu.21388","volume":"32","author":"MS Ebberink","year":"2011","unstructured":"Ebberink MS, Mooijer PAW, Gootjes J et al (2011) Genetic classification and mutational spectrum of more than 600 patients with a Zellweger syndrome spectrum disorder. Hum Mutat 32:59\u201369. https:\/\/doi.org\/10.1002\/humu.21388","journal-title":"Hum Mutat"},{"key":"684_CR17","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.bbadis.2012.04.006","volume":"1822","author":"HR Waterham","year":"2012","unstructured":"Waterham HR, Ebberink MS (2012) Genetics and molecular basis of human peroxisome biogenesis disorders. Biochim Biophys Acta 1822:1430\u20131441. https:\/\/doi.org\/10.1016\/j.bbadis.2012.04.006","journal-title":"Biochim Biophys Acta"},{"key":"684_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1006\/bbrc.2002.6642","volume":"292","author":"N Shimozawa","year":"2002","unstructured":"Shimozawa N, Nagase T, Takemoto Y et al (2002) A novel aberrant splicing mutation of the PEX16 gene in two patients with Zellweger syndrome. Biochem Biophys Res Commun 292:109\u2013112. https:\/\/doi.org\/10.1006\/bbrc.2002.6642","journal-title":"Biochem Biophys Res Commun"},{"key":"684_CR19","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1086\/302161","volume":"63","author":"M Honsho","year":"1998","unstructured":"Honsho M, Tamura S, Shimozawa N et al (1998) Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D. Am J Hum Genet 63:1622\u20131630. https:\/\/doi.org\/10.1086\/302161","journal-title":"Am J Hum Genet"},{"key":"684_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1399-0004.2010.01498.x","volume":"79","author":"R Shaheen","year":"2011","unstructured":"Shaheen R, Al-Dirbashi O, Al-Hassnan Z et al (2011) Clinical, biochemical and molecular characterization of peroxisomal diseases in Arabs. Clin Genet 79:60\u201370. https:\/\/doi.org\/10.1111\/j.1399-0004.2010.01498.x","journal-title":"Clin Genet"},{"key":"684_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00431-014-2431-2","volume":"174","author":"V Salpietro","year":"2015","unstructured":"Salpietro V, Phadke R, Saggar A et al (2015) Zellweger syndrome and secondary mitochondrial myopathy. Eur J Pediatr 174:557\u2013563. https:\/\/doi.org\/10.1007\/s00431-014-2431-2","journal-title":"Eur J Pediatr"},{"key":"684_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.braindev.2018.07.015","volume":"41","author":"NA Zaabi","year":"2019","unstructured":"Zaabi NA, Kendi A, Al-Jasmi F et al (2019) Atypical PEX16 peroxisome biogenesis disorder with mild biochemical disruptions and long survival. Brain Dev 41:57\u201365. https:\/\/doi.org\/10.1016\/j.braindev.2018.07.015","journal-title":"Brain Dev"},{"key":"684_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ymgmr.2018.07.003","volume":"16","author":"KR Kumar","year":"2018","unstructured":"Kumar KR, Wali G, Davis RL et al (2018) Expanding the spectrum of PEX16 mutations and novel insights into disease mechanisms. Mol Genet Metab Rep 16:46\u201351. https:\/\/doi.org\/10.1016\/j.ymgmr.2018.07.003","journal-title":"Mol Genet Metab Rep"},{"key":"684_CR24","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1136\/jmg.2009.074302","volume":"47","author":"MS Ebberink","year":"2010","unstructured":"Ebberink MS, Csanyi B, Chong WK et al (2010) Identification of an unusual variant peroxisome biogenesis disorder caused by mutations in the PEX16 gene. J Med Genet 47:608\u2013615. https:\/\/doi.org\/10.1136\/jmg.2009.074302","journal-title":"J Med Genet"},{"key":"684_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ymgmr.2015.09.001","volume":"5","author":"CA Bacino","year":"2015","unstructured":"Bacino CA, Chao Y-H, Seto E et al (2015) A homozygous mutation in PEX16 identified by whole-exome sequencing ending a diagnostic odyssey. Mol Genet Metab Rep 5:15\u201318. https:\/\/doi.org\/10.1016\/j.ymgmr.2015.09.001","journal-title":"Mol Genet Metab Rep"},{"key":"684_CR26","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1177\/088307389901400705","volume":"14","author":"M Pineda","year":"1999","unstructured":"Pineda M, Gir\u00f3s M, Roels F et al (1999) Diagnosis and follow-up of a case of peroxisomal disorder with peroxisomal mosaicism. J Child Neurol 14:434\u2013439. https:\/\/doi.org\/10.1177\/088307389901400705","journal-title":"J Child Neurol"},{"key":"684_CR27","doi-asserted-by":"publisher","unstructured":"Ersoy M, TatlA B (2016) A novel mutation of the PEX16 gene in a patient with slowly progressive Zellweger syndrome. J Clin Case Rep 6.https:\/\/doi.org\/10.4172\/2165-7920.1000854","DOI":"10.4172\/2165-7920.1000854"},{"key":"684_CR28","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.parkreldis.2019.06.008","volume":"65","author":"Y-J Chen","year":"2019","unstructured":"Chen Y-J, Wang M-W, Dong E-L et al (2019) Chinese patients with adrenoleukodystrophy and Zellweger spectrum disorder presenting with hereditary spastic paraplegia. Parkinsonism Relat Disord 65:256\u2013260. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.06.008","journal-title":"Parkinsonism Relat Disord"},{"key":"684_CR29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10048-013-0375-8","volume":"14","author":"C Ohba","year":"2013","unstructured":"Ohba C, Osaka H, Iai M et al (2013) Diagnostic utility of whole exome sequencing in patients showing cerebellar an. Neurogenetics 14:225\u2013232. https:\/\/doi.org\/10.1007\/s10048-013-0375-8","journal-title":"Neurogenetics"},{"key":"684_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10545-015-9880-2","volume":"39","author":"K Berendse","year":"2016","unstructured":"Berendse K, Engelen M, Ferdinandusse S et al (2016) Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood. J Inherit Metab Dis 39:93\u2013106. https:\/\/doi.org\/10.1007\/s10545-015-9880-2","journal-title":"J Inherit Metab Dis"},{"key":"684_CR31","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1542\/peds.111.1.e89","volume":"111","author":"TD Sanger","year":"2003","unstructured":"Sanger TD, Delgado MR, Gaebler-Spira D et al (2003) Classification and definition of disorders causing hypertonia in childhood. Pediatrics 111:e89\u2013e97. https:\/\/doi.org\/10.1542\/peds.111.1.e89","journal-title":"Pediatrics"},{"key":"684_CR32","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1086\/503921","volume":"78","author":"S Ferdinandusse","year":"2006","unstructured":"Ferdinandusse S, Kostopoulos P, Denis S et al (2006) Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy. Am J Hum Genet 78:1046\u20131052. https:\/\/doi.org\/10.1086\/503921","journal-title":"Am J Hum Genet"},{"key":"684_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/8904_2014_305","volume-title":"Deep brain stimulation and dantrolene for secondary dystonia in X-linked adrenoleukodystrophy","author":"C van Karnebeek","year":"2014","unstructured":"van Karnebeek C, Horvath G, Murphy T et al (2014) Deep brain stimulation and dantrolene for secondary dystonia in X-linked adrenoleukodystrophy. Springer, Berlin Heidelberg, Berlin, Heidelberg"},{"key":"684_CR34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ejpn.2017.09.003","volume":"22","author":"HT Hjartarson","year":"2018","unstructured":"Hjartarson HT, Ehrstedt C, Tedroff K (2018) Intrathecal baclofen treatment an option in X-linked adrenoleukodystrophy. Eur J Paediatr Neurol 22:178\u2013181. https:\/\/doi.org\/10.1016\/j.ejpn.2017.09.003","journal-title":"Eur J Paediatr Neurol"},{"key":"684_CR35","first-page":"195","volume":"54","author":"S Mishra","year":"2006","unstructured":"Mishra S, Modi M, Das CP, Prabhakar S (2006) Adrenoleukodystrophy manifesting as spinocerebellar degeneration. Neurol India 54:195\u2013196","journal-title":"Neurol India"},{"key":"684_CR36","first-page":"600","volume":"32","author":"Y Shiga","year":"1992","unstructured":"Shiga Y, Saito H, Mochizuki H et al (1992) A case of adrenoleukodystrophy having progressed from the frontal lobes. Rinsho Shinkeigaku 32:600\u2013605","journal-title":"Rinsho Shinkeigaku"},{"key":"684_CR37","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1111\/febs.14607","volume":"285","author":"DJ Surmeier","year":"2018","unstructured":"Surmeier DJ (2018) Determinants of dopaminergic neuron loss in Parkinson\u2019s disease. FEBS J 285:3657\u20133668. https:\/\/doi.org\/10.1111\/febs.14607","journal-title":"FEBS J"},{"key":"684_CR38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1126\/science.182.4107.62","volume":"182","author":"S Goldfischer","year":"1973","unstructured":"Goldfischer S, Moore CL, Johnson AB et al (1973) Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science 182:62\u201364. https:\/\/doi.org\/10.1126\/science.182.4107.62","journal-title":"Science"},{"key":"684_CR39","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/S0002-9440(10)62534-5","volume":"159","author":"E Baumgart","year":"2001","unstructured":"Baumgart E, Vanhorebeek I, Grabenbauer M et al (2001) Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse). Am J Pathol 159:1477\u20131494. https:\/\/doi.org\/10.1016\/S0002-9440(10)62534-5","journal-title":"Am J Pathol"},{"key":"684_CR40","doi-asserted-by":"publisher","DOI":"10.7916\/D8V69X3S","author":"HA Jinnah","year":"2017","unstructured":"Jinnah HA, Neychev V, Hess EJ (2017) The anatomical basis for dystonia: the motor network model. Tremor Hyperkinetic Mov Tremor and Other Hyperkinetic Movements. https:\/\/doi.org\/10.7916\/D8V69X3S","journal-title":"Tremor Hyperkinetic Mov Tremor and Other Hyperkinetic Movements"},{"key":"684_CR41","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/ng1403","volume":"36","author":"JA Holbrook","year":"2004","unstructured":"Holbrook JA, Neu-Yilik G, Hentze MW, Kulozik AE (2004) Nonsense-mediated decay approaches the clinic. Nat Genet 36:801\u2013808. https:\/\/doi.org\/10.1038\/ng1403","journal-title":"Nat Genet"},{"key":"684_CR42","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/tra.12292","volume":"16","author":"R Hua","year":"2015","unstructured":"Hua R, Gidda SK, Aranovich A et al (2015) Multiple domains in PEX16 mediate its trafficking and recruitment of peroxisomal proteins to the ER: analysis of PEX16 functional domains. Traffic 16:832\u2013852. https:\/\/doi.org\/10.1111\/tra.12292","journal-title":"Traffic"}],"container-title":["neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-022-00684-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-022-00684-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-022-00684-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T14:08:57Z","timestamp":1648476537000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-022-00684-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["684"],"URL":"https:\/\/doi.org\/10.1007\/s10048-022-00684-7","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,2]]},"assertion":[{"value":"22 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the McGill University Health Center (MUHC) Research Ethics Board (11\u2013090-PED).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent to participate in this study was obtained from all patients and\/or families involved.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent for publication of this study was obtained from all patients and\/or families involved. Additional informed consent was obtained from the individuals whose photos have been included in this publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.This work was partially presented in a virtual podium presentation at the American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting in April 2021.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}